Partner news
News
Partner news
F-star Therapeutics Announces License Agreement with Janssen to Develop and Commercialize Multiple Next Generation Bispecific Antibody Therapeutics
Read full storyPartner news
Apollo Therapeutics Completes $145 Million Financing Led by Patient Square Capital to Expand and Advance Portfolio-Based Drug Development
Read full storyPartner news
Oxford to collaborate with Janssen to map the cellular landscape of immune mediated disorders
Read full storyPartner news
Exonate announces the initiation of Phase Ib/II clinical trial for Diabetic Macular Oedema, as part of its collaboration with Janssen
Read full storyPartner news
£10 million research collaboration to detect lung cancer earlier
Read full storyPartner news
Revitope Oncology Announces Strategic Collaboration with Janssen to Leverage its Unique T Cell Engager Platform
Read full storyPartner news
Morphic Expands Research and Development Collaboration with Janssen Through Third Integrin Program
Read full storyPartner news
UK Biobank launches one of the largest scientific studies measuring circulating proteins, to better understand the link between genetics and human disease
Read full storyPartner news
Koa Health to collaborate with Janssen: Official press release
Read full storyPartner news
BaseLaunch announces that Johnson & Johnson Innovation has renewed its commitment becoming latest strategic partner in the second phase
Read full storyPartner news
Imec collaborates with Janssen to advance precision medicine to treat and eliminate disease
Read full storyPartner news
Exonate Announces Collaboration with Janssen to develop a new eye drop for the treatment of retinal vascular diseases including wet age-related macular degeneration (AMD) and diabetic macular oedema (DMO)
Read full storyPartner news
Medicines Discovery Catapult, MQ: Transforming mental health and Alzheimer’s Research UK announce an innovative drug discovery consortium with industry, supported by the Wellcome Trust.
Read full storyPartner news